Medicare Enrolled

Dr. Yevgeniy Veltman, M.D.

Urology Physician · San Francisco, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2186 GEARY BLVD STE 214, San Francisco, CA 94115
4159223255
In practice since 2008 (17 years)
NPI: 1497917579 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Veltman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Veltman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Veltman

Dr. Yevgeniy Veltman is an urology physician in San Francisco, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Veltman performed 3,352 Medicare services across 2,184 unique beneficiaries.

Between the years covered by Open Payments, Dr. Veltman received a total of $9,706 from 41 pharmaceutical and/or device companies across 390 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Veltman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 25% volume in CA $9,706 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,352
Medicare services
Top 25% in CA for urology physician
2,184
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~197 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,342 $65 $193
Manual urinalysis with microscopic examination
A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities.
828 $4 $9
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
404 $10 $28
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
222 $99 $271
Leuprolide acetate (for depot suspension), 7.5 mg 114 $135 $500
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
98 $133 $391
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
94 $7 $33
Complex urodynamic pressure flow study
A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning.
86 $344 $970
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
51 $221 $635
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
33 $32 $86
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
20 $112 $287
3D radiographic procedure with computerized image postprocessing
A radiographic imaging procedure that creates three-dimensional images using computerized processing of the captured data.
20 $34 $87
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
20 $29 $75
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
20 $27 $69
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,706
Total received (2018-2024)
Avg $1,387/year across 7 years
Top 21% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
390
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,706 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,433
2023
$1,599
2022
$1,801
2021
$1,858
2020
$1,207
2019
$1,408
2018
$401

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$552
Astellas Pharma US Inc
$232
Antares Pharma, Inc.
$120
Blue Earth Diagnostics Limited
$117
PFIZER INC.
$92
ABBVIE INC.
$85
Janssen Biotech, Inc.
$63
ACCORD HEALTHCARE, INC.
$49
Myriad Genetic Laboratories, Inc.
$45
Olympus America Inc.
$41
IMMUNITYBIO, INC.
$35
Top 3 companies account for 63.1% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,690
Sumitomo Pharma America, Inc.
$1,278
UROVANT SCIENCES INC
$872
Janssen Biotech, Inc.
$613
AbbVie Inc.
$599
Boston Scientific Corporation
$597
Blue Earth Diagnostics Limited
$364
BOSTON SCIENTIFIC CORPORATION
$332
ABBVIE INC.
$327
PFIZER INC.
$323
Allergan Inc.
$306
NeoTract Inc.
$241
Ferring Pharmaceuticals Inc.
$223
Dendreon Pharmaceuticals LLC
$220
Dornier MedTech America, Inc
$205
Allergan, Inc.
$183
Antares Pharma, Inc.
$164
Bayer HealthCare Pharmaceuticals Inc.
$129
AbbVie, Inc.
$109
Myovant Sciences Inc.
$78
ACCORD HEALTHCARE, INC.
$78
Endo Pharmaceuticals Inc.
$67
Rochester Medical Corporation
$63
Olympus America Inc.
$59
Agiliti Surgical, Inc.
$59
GE HealthCare
$56
KARL STORZ Endoscopy-America
$54
Myriad Genetic Laboratories, Inc.
$45
Photocure Inc
$43
UroGen Pharma, Inc.
$42
Laborie Medical Technologies Corp.
$36
AngioDynamics, Inc.
$35
IMMUNITYBIO, INC.
$35
PROCEPT BioRobotics Corporation
$29
Bayer Healthcare Pharmaceuticals Inc.
$29
UROGEN PHARMA, INC.
$25
Supernus Pharmaceuticals, Inc.
$25
Coloplast Corp
$22
SRS Medical Systems, Inc.
$17
Acerus Pharmaceuticals Corporation
$16
Sagent Pharmaceuticals
$15
Top 3 companies account for 39.6% of all-time payments
Associated products mentioned in payments ›
ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AVEED · Axumin · BOTOX · BOTOX THERAPEUTIC · CAMCEVI · CYSVIEW · Cysview · Dornier MedTech · ERLEADA · Erleada · FIRMAGON · FLEX-XC CMOS URETEROSCOPE 8.5 FR X 675MM · FLEXIVA · GEMTESA · GENERAL BPH · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · GENERAL - BPH · GENERAL - FEMALE SUI · General - Kidney Stone Disease · Glydo · GreenLight XPS · JELMYTO · LITHOCATCH · LITHOVUE · LUPRON DEPOT · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · NanoKnife · Natesto · Nubeqa · ORGOVYX · PENILE & TESTICULAR RECONSTRUCTN · POSLUMA · PROLARIS · PROVENGE · REZUM · TOVIAZ · UroCuff · UroLift · VRAYLAR · Veozah · XTANDI · XYOSTED · Xofigo · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in San Francisco?
Compare urology physicians in the San Francisco area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
134
Per 100K population
16.0
County median income
$141,446
Nearest hospital
KAISER FOUNDATION HOSPITAL - SAN FRANCISCO
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Veltman is a clinical cardiology specialist, with above-average Medicare volume (top 25% in CA), with low-engagement industry engagement, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Veltman experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Veltman performed 1,342 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Veltman receive payments from pharmaceutical companies?
Yes. Dr. Veltman received a total of $9,706 from 41 companies across 390 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Veltman's costs compare to other urology physicians in San Francisco?
Dr. Veltman's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Veltman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →